Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. - Wikidata - awgldk - TriplyDB

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

http://www.wikidata.org/entity/Q37698325

about

Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute Open-access biorepository for idiopathic pulmonary fibrosis. The way forward The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair Hsp90 regulation of fibroblast activation in pulmonary fibrosis.Looking Back at My American Thoracic Society Presidency. Attracting and Retaining the Next Generation.An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.Alveolar epithelium: beyond the barrier.TRIM72 is required for effective repair of alveolar epithelial cell wounding.New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.MiRNA-30a inhibits AECs-II apoptosis by blocking mitochondrial fission dependent on Drp-1.Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.Glutamine and alanyl-glutamine promote crypt expansion and mTOR signaling in murine enteroids.mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis.The need for patient-centred clinical research in idiopathic pulmonary fibrosis Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.Plasma Glutamine Concentrations in Liver Failure.Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition.FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis Human airway organoid engineering as a step toward lung regeneration and disease modeling.A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy.Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1.Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension TRIM72 modulates caveolar endocytosis in repair of lung cells.Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis.Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π.Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study.Plasma glutamine levels before cardiac surgery are related to post-surgery infections; an observational study.Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis.Epigenetic targets for novel therapies of lung diseases.Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis.

P2860

Q26797452-79BE3D1A-D565-4A1C-B062-16C81BD7A53A Q26852563-7E359D5A-1A52-4F3D-AB43-646AA1A9F49C Q27003322-CC96E690-BAFF-4C6D-80B0-8471514FAD45 Q27005980-20C798F3-4AD6-4388-BA48-778FBD5FFE20 Q28386563-339B4E05-2070-4150-8CA3-0CC4EBEAFB3D Q30838920-A584F004-07D0-422F-811E-49BB63963338 Q33712616-52017BB1-DD5B-4B91-B62F-2F492065437F Q33714184-489B34D7-BAB6-4266-9030-9D504A0E7F2B Q33799762-0D1F71F1-6937-42BD-BEF7-5FD4F8C12440 Q34201280-1367252E-DD93-4E11-92B2-DEA1A94B0C16 Q34432217-31B66019-8F54-4919-8EBA-8588A1804A86 Q34998361-7BF36174-0BC7-40E6-8CED-B2D1805B77BB Q35121494-BF271096-D2FB-4E7D-8C5D-62DE8CDC9807 Q35207699-4AF9D49C-CFAB-4952-8D6E-7311DC7EE1D4 Q35236478-F0BFC29E-D093-4202-A87F-D9FAFFE8F4E9 Q35622554-E3033792-06ED-4C0A-9170-7812A9B6A92E Q35780096-D3D83539-CF47-42D6-B109-50F3FA6CA6C8 Q35785546-7C7E6346-907B-4A18-A86B-06A1D8B1CE21 Q35801391-20DBFF1A-E29E-4F9A-B284-0E9C40AAC3BE Q35944467-3F4FE197-04D7-41E4-95B1-65FEA940D720 Q35953209-2C8CB392-5C48-4965-9B22-AD531B0E73F9 Q36066466-DCCDD1C8-8984-44D5-A475-A80BC78A42F2 Q36099932-F5752060-B113-4951-B020-2FF41EA0739C Q36128503-1927092B-8F79-4DFA-9ACD-7475BA855D07 Q36183446-C33978E3-2ED7-4B44-B9DC-54BBE63C5C61 Q36438280-F3B23DFE-E104-4F74-85D8-65F51EB888CA Q36444154-3C39B04E-2A97-4213-B453-C659B720A194 Q36548944-0B4CE5C8-781B-4CF0-8A10-D9178B27ECD0 Q36608217-BD40FBF8-B04B-448C-A8E2-884B00422A75 Q36638484-EB72B5B0-17DB-455E-83F5-CB3DD471FA4E Q36685226-DE4578E9-C5B0-4BB3-9F5D-FC77B08367E3 Q36765972-83C85F2E-D6B9-4BAD-BA00-D0EF850FCFFB Q36765978-9A193FF7-C5DC-412A-B391-5747D8D3EFCA Q37041521-05E68B77-5D1A-421B-B1AA-62BAB064664B Q37144755-DD36D5F1-7F5B-408A-AF91-5A40E1C85B41 Q37440020-383DE3EB-DA44-4EFB-BBDF-B9344205EE89 Q37469191-A635E19E-FCA5-4F03-9238-C57A22236EFC Q37538264-8059C5BD-CA06-40D7-AF60-8E734E7B2F0B Q38275276-E1258425-64B1-4189-990E-405DAB651CB5 Q38367113-3C9009DA-B967-43D4-A97B-579088489DBD

P2860

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

http://www.wikidata.org/entity/Q37698325

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@en

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@nl

type

label

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@en

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@nl

prefLabel

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@en

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@nl

P1433

Q37698325-FD87B7B6-23CA-487E-BDCB-0577DD381F62

P1476

Q37698325-42E6F7BF-4791-4CB8-9DFA-F7EA3FF153C9

P2093

Q37698325-0629EF87-0590-4741-9FF2-6B7AB48AC11C

Q37698325-0E81B121-B9A4-4F25-967E-86A293BC5170

Q37698325-0EEA133E-FFE5-4FC1-AEB3-808C0833A451

Q37698325-1537B232-D57F-4AAC-9814-C8A6721CA346

Q37698325-19AEBDE7-7D52-4635-8189-BDBD97F9608B

Q37698325-19C677D4-5CC7-4A6C-807F-ADE8BA70CCEF

Q37698325-1F52F57A-D99E-4C5D-80E0-A0A307CD5BDD

Q37698325-1FBDECFB-A39A-4568-B017-2A9093B7C8E0

Q37698325-2C7980E8-1498-4B6B-85A3-56285E403AF5

Q37698325-3D34AC27-2D6B-4596-A434-C0E234E4492B

P2860

Q37698325-050BD615-3C56-4A4F-B86A-B4C1BE10E8FE

Q37698325-09EE3791-2596-4E17-9262-04419F6A22F1

Q37698325-0E9F6058-8B8C-47E0-84A5-8C2506514BC2

Q37698325-0FAD8421-24C0-41CB-8194-308A6903D58E

Q37698325-12AF7A26-E5CA-4A6E-9406-B9A523D3AC3B

Q37698325-13994C66-AD69-4819-895F-F28C48EF4915

Q37698325-16DFA2CF-874C-4B01-8D52-9AE9D20930A9

Q37698325-1831A31E-2B06-40FA-AC8A-42FDEFD4E3C1

Q37698325-1A6D3B12-D02A-47D9-B7C1-7F22556388BC

Q37698325-1F279A0D-4874-4724-AAF2-7E71A76CF7B5

P2888

Q37698325-BA72BE5F-AD8D-414A-AFBE-FCED5839893B

P304

Q37698325-B66D9CDA-0F49-4EC4-9B8B-BCD6BFF7BFE2

P31

Q37698325-AF1C1C50-A49B-4C95-BB53-E1FB8571B0BF

P356

Q37698325-5C4F86BB-727C-4A99-9705-41CE80D56A9A

Q37698325-FA9063D2-4855-4FFE-9AB0-BAB9313904F1

P407

Q37698325-AF489291-DC96-43DD-91CD-BDAF46A84A55

P433

Q37698325-3076E4FA-0B0A-4ED2-87F4-F33E75C498D7

P478

Q37698325-20188028-2ED8-40F5-956B-9E2F43A60D83

P50

Q37698325-08B2F923-47E7-496D-AB9B-D4160D88159C

Q37698325-19F6DA7B-EB4C-4A86-8413-5E371E430CC7

Q37698325-29A3FBDE-3448-4C43-9B7E-F28B79EB29EA

Q37698325-352D7681-3029-4D11-B17E-8AB6F266BE21

Q37698325-38DFE8AD-A871-427B-ABC6-102624720C0C

Q37698325-56FBC356-6171-4DE9-9ED4-03859B4F0CF7

Q37698325-A32092F5-1AC6-482B-8799-4E20FBE89A2F

Q37698325-F1E02ABA-860B-4110-AB16-0FCBA961700F

Q37698325-F58A9EE0-4F93-4ACD-9C6A-BDBA30125D9E

P577

Q37698325-7C8552A6-2147-415E-B8DB-9A56610B9C29

P5875

Q37698325-73019887-610A-4C0E-9E83-8AF8F6610107

P6179

Q37698325-F802DB66-58D8-450E-BE53-0E5ECBC806E1

P698

Q37698325-6aa9c151-e22a-4ac3-badf-3f792928c1cc

Q37698325-B2002347-EA07-4834-ADAF-922C56B5108F

P921

Q37698325-072FE129-A5F5-4A6D-AE89-EBEC24171D1C

Q37698325-74A60884-0A6A-466C-BAB2-F0F491FA2B39

P932

Q37698325-D3DD3CBB-0A14-4F3D-B603-2C861A883BD9

P356

RCCM.201306-1141WS

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

@en

P2093

Andrew M Tager

http://www.w3.org/2001/XMLSchema#string

Christine Kim Garcia

http://www.w3.org/2001/XMLSchema#string

Clay B Marsh

http://www.w3.org/2001/XMLSchema#string

Cory M Hogaboam

http://www.w3.org/2001/XMLSchema#string

Craig A Henke

http://www.w3.org/2001/XMLSchema#string

Daniel Tschumperlin

http://www.w3.org/2001/XMLSchema#string

David A Schwartz

http://www.w3.org/2001/XMLSchema#string

Dean Sheppard

http://www.w3.org/2001/XMLSchema#string

Erica Herzog

http://www.w3.org/2001/XMLSchema#string

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix

The myofibroblast: one function, multiple origins

Host responses in tissue repair and fibrosis

Peripheral blood biomarkers in idiopathic pulmonary fibrosis

Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

P2888

P304

214-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201306-1141WS

http://www.w3.org/2001/XMLSchema#string

10.1186/CC13781

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

Bethany B Moore

Naftali Kaminski

Jeffrey C. Horowitz

Michael R. Blackburn

Peter B Bitterman

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264008642

http://www.w3.org/2001/XMLSchema#string

P6179

1040247178

http://www.w3.org/2001/XMLSchema#string

P698

24160862

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3983890

http://www.w3.org/2001/XMLSchema#string